Q4 2023 · 13F-HR
CAXTON CORPholdings as filed
Filed 2024-02-14 · accession 0000919574-24-001188
$18.5M
Reported value
12
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $13.3M | 71.6% | 5,641,920 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $1.7M | 8.97% | 353,441 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.3M | 7.07% | 1,318,967 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $628,144 | 3.39% | 1,322 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $510,510 | 2.76% | 136,866 | Common | SOLE |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $369,293 | 1.99% | 1,035 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $205,436 | 1.11% | 7,353 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $179,149 | 0.97% | 16,743 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $138,476 | 0.75% | 10,319 | Common | SOLE |
| 41358P205 | HARPUSD | HARPOON THERAPEUTICS INC | $129,291 | 0.70% | 13,176 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $67,806 | 0.37% | 43,465 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $67,457 | 0.36% | 24,710 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.